UnitedHealth Group Incorporated (NYSE:UNH) is Rhenman & Partners Asset Management AB’s 7th Largest Position

Rhenman & Partners Asset Management AB boosted its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 17.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 54,000 shares of the healthcare conglomerate’s stock after purchasing an additional 8,000 shares during the period. UnitedHealth Group makes up 2.8% of Rhenman & Partners Asset Management AB’s portfolio, making the stock its 7th largest position. Rhenman & Partners Asset Management AB’s holdings in UnitedHealth Group were worth $28,429,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the 4th quarter valued at about $26,000. CGC Financial Services LLC increased its position in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the period. LFA Lugano Financial Advisors SA increased its position in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the period. O Brien Wealth Partners LLC increased its position in UnitedHealth Group by 36.8% during the 4th quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock worth $41,000 after purchasing an additional 21 shares during the period. Finally, Friedenthal Financial acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $42,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $8.05 during mid-day trading on Tuesday, reaching $505.49. 3,158,834 shares of the company traded hands, compared to its average volume of 4,199,293. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market cap of $465.25 billion, a PE ratio of 30.73, a price-to-earnings-growth ratio of 1.44 and a beta of 0.58. The stock has a fifty day simple moving average of $489.82 and a 200-day simple moving average of $508.65.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter last year, the business earned $6.26 earnings per share. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on UNH shares. Barclays boosted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Piper Sandler increased their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Royal Bank of Canada reduced their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Finally, TD Cowen reduced their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $572.75.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.